Last updated on July 2019

Study of Durvalumab+Olaparib or Durvalumab After Treatment With Durvalumab and Chemotherapy in Patients With Lung Cancer (ORION)


Brief description of study

This is a randomized, double-blind, multi-center, global Phase II study to determine the efficacy and safety of Durvalumab plus Olaparib combination therapy compared with Durvalumab monotherapy as maintenance therapy in patients whose disease has not progressed following Standard of Care (SoC) platinum-based chemotherapy with Durvalumab as first-line treatment in patients with Stage IV non small-cell lung cancer (NSCLC) with tumors that lack activating epidermal growth factor receptor (EGFR) mutations and anaplastic lymphoma kinase (ALK) fusions.

Detailed Study Description

Adult patients with a histologically or cytologically documented advanced NSCLC not amenable to curative surgery or radiation with tumors that lack activation EGFR mutations and ALK fusions are eligible for enrollment. During the initial therapy phase, patients will receive treatment with Durvalumab along with the Investigator's choice of platinum-based doublet therapy for squamous NSCLC (nab-paclitaxel plus carboplatin or gemcitabine plus carboplatin/cisplatin) and non-squamous NSCLC (nab-paclitaxel plus carboplatin or pemetrexed plus carboplatin/cisplatin) for 4 cycles. Patients who have completed 4 cycles and not progressed throughout the initial therapy phase will be randomized in a 1:1 ratio into the maintenance phase of the study to receive either Durvalumab plus placebo or Durvalumab plus Olaparib maintenance therapy. Patients will receive maintenance treatment until specific discontinuation criteria are met, including clinical disease progression (as assessed by the Investigator) or RECIST 1.1-defined radiological Progressive Disease (PD), unacceptable toxicity, and withdrawal of consent. Tumor evaluation scans will be performed until objective disease progression as efficacy assessments. All patients will be followed for survival until the end of the study.

Clinical Study Identifier: NCT03775486

Find a site near you

Start Over

Research Site

Fullerton, CA United States
  Connect »

Research Site

Norwich, CT United States
  Connect »

Research Site

Bonita Springs, FL United States
  Connect »

Research Site

Saint Petersburg, FL United States
  Connect »

Research Site

Nashville, TN United States
  Connect »

Research Site

Roeselare, Belgium
  Connect »

Research Site

Bordeaux Cedex, France
  Connect »

Research Site

Montpellier, France
  Connect »

Research Site

Rennes Cedex 9, France
  Connect »

Research Site

Saint-Mande, France
  Connect »

Research Site

Saint-Quentin cedex, France
  Connect »

Research Site

Budapest, Hungary
  Connect »

Research Site

Debrecen, Hungary
  Connect »

Research Site

Farkasgyepü, Hungary
  Connect »

Research Site

Törökbálint, Hungary
  Connect »

Research Site

Ahmedabad, India
  Connect »

Research Site

Bangalore, India
  Connect »

Research Site

Thiruvananthapuram, India
  Connect »

Research Site

Dongjakgu, Korea, Republic of
  Connect »

Research Site

Goyang-si, Korea, Republic of
  Connect »

Research Site

Seodaemungu, Korea, Republic of
  Connect »

Research Site

Seoul, Korea, Republic of
  Connect »

Research Site

Suweonsi Paldalgu, Korea, Republic of
  Connect »

Research Site

Chihuahua, Mexico
  Connect »

Research Site

San Luis Potosí, Mexico
  Connect »

Research Site

Arnhem, Netherlands
  Connect »

Research Site

Blaricum, Netherlands
  Connect »

Research Site

Harderwijk, Netherlands
  Connect »

Research Site

Tilburg, Netherlands
  Connect »

Research Site

Chrzanów, Poland
  Connect »

Research Site

Farkasgyepü, Hungary
  Connect »

Research Site

Törökbálint, Hungary
  Connect »

Research Site

San Luis Potosí, Mexico
  Connect »

Research Site

Chrzanów, Poland
  Connect »

Research Site

Farkasgyepü, Hungary
  Connect »

Research Site

Törökbálint, Hungary
  Connect »

Research Site

San Luis Potosí, Mexico
  Connect »

Research Site

Chrzanów, Poland
  Connect »

Research Site

Farkasgyepü, Hungary
  Connect »

Research Site

Törökbálint, Hungary
  Connect »

Research Site

San Luis Potosí, Mexico
  Connect »

Research Site

Chrzanów, Poland
  Connect »

Research Site

Farkasgyepü, Hungary
  Connect »

Research Site

Törökbálint, Hungary
  Connect »

Research Site

Seodaemun-gu, Korea, Republic of
  Connect »

Research Site

San Luis Potosí, Mexico
  Connect »

Research Site

Chrzanów, Poland
  Connect »

Research Site

Farkasgyepü, Hungary
  Connect »

Research Site

Törökbálint, Hungary
  Connect »

Research Site

San Luis Potosí, Mexico
  Connect »

Research Site

Chrzanów, Poland
  Connect »